title: External beam radiotherapy (20 Gy, 2 Gy fractions) fails to control the growth of choroidal neovascularization in age-related macular degeneration: a review of 111 cases.
abstract: BACKGROUND
  Control of the natural course of choroidal neovascularization (CNV) in age-related macular degeneration (ARMD) is difficult, and laser photocoagulation is recommended in only a subset of patients. Alternative modalities of treatment are under investigation.
  
  
  METHODS
  We have used external beam radiotherapy (20 gray radiation units [Gy], 2 Gy fractions) to treat CNV in ARMD. A total of 111 patients have been followed for 12-30 months after radiotherapy. This study evaluates the effect of radiotherapy on the size of CNV, which was digitally measured on serial fluorescein angiograms.
  
  
  RESULTS
  Analysis of results in the classic (or mixed classic and occult) CNV group was conclusive for fast growth of CNV and continuous increase of size during follow up. In the occult CNV group, a slowly progressive growth of CNV was demonstrated. In patients with vascularized pigment epithelium detachments, "hot spots" persisted; in a few patients, flattening of the macula was observed. Nearly all treated patients experienced further loss of vision. CNV growth in the radiotherapy treated eye was usually similar to growth in the untreated fellow eye, and in some, even worse.
  
  
  CONCLUSIONS
  External beam radiotherapy (20 Gy, 2 Gy fractions) failed to control growth of CNV and was ineffective in stabilizing vision.
authors.affiliation: Department of Ophthalmology, University Hospitals of Leuven, Belgium.
authors.forename: P
authors.initials: P
authors.lastname: Stalmans
authors.forename: A
authors.initials: A
authors.lastname: Leys
authors.forename: E
authors.initials: E
authors.lastname: Van Limbergen
mesh_terms: D000368:Aged; D002829:Choroid / Q000098:blood supply* / Q000528:radiation effects; D018450:Disease Progression; D019583:Dose Fractionation, Radiation; D005451:Fluorescein Angiography; D005500:Follow-Up Studies; D005654:Fundus Oculi; D006801:Humans; D007091:Image Processing, Computer-Assisted; D008268:Macular Degeneration / Q000150:complications* / Q000175:diagnosis; D009389:Neovascularization, Pathologic / Q000209:etiology / Q000503:physiopathology / Q000532:radiotherapy*; D011882:Radiotherapy, High-Energy; D016896:Treatment Outcome; D014792:Visual Acuity